APEX2 and prostate carcinoma: A pan-cancer analysis from TCGA database and cBioPortal has identified APE2 overexpression at mRNA level in tumor tissues compared with adjacent non-malignant tissues from kidney cancer, breast cancer, lung cancer, liver cancer, and prostate cancer (Jensen et al., 2020).